The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche; Sanofi
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; MSD; Roche; Sanofi
Baseline circulating myeloid-derived suppressor cells subpopulations, neutrophils/lymphocytes ratio, and response to PD-1/PD-L1 inhibitor in non-small cell lung cancer patients.
 
JosE GarcIa SAnchez
Consulting or Advisory Role - Boehringer Ingelheim; EUSA Pharma; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Marta Benet Gimenez
No Relationships to Disclose
 
Lourdes Cordón
No Relationships to Disclose
 
Maria De Julian
Speakers' Bureau - Acraf; MSD; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Acraf; AstraZeneca; Boehringer Ingelheim
 
Marta Piqueras
No Relationships to Disclose
 
Veronica Ruiz
No Relationships to Disclose
 
Javier Garde
No Relationships to Disclose
 
Nuria Piera
Consulting or Advisory Role - Kiowa Kirin
Travel, Accommodations, Expenses - Roche
 
Alfredo Sanchez
No Relationships to Disclose
 
David Lorente
Consulting or Advisory Role - Bayer Health; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer Health; Bristol-Myers Squibb; Janssen; Sanofi
Travel, Accommodations, Expenses - Astellas Oncology; Celgene; Janssen; Pfizer; Sanofi
 
Julian Carretero
Patents, Royalties, Other Intellectual Property - Spanish National Cancer Center
 
Oscar Juan-Vidal
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Pfizer; Roche/Genentech; Takeda
Research Funding - AstraZeneca Spain (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
 
Agustin Lahoz
No Relationships to Disclose